RMT Podcast #89 – Williams, Borovetz, and Winowich

Regenerative Medicine Today welcomes Dr. Harvey Borovetz, Mr. Stephen Winowich, and Mr. Brian Williams. Dr. Borovetz and Mr. Winowich discuss the early days of Ventricular Assist Devices, and Mr. Williams recounts his experience as one of the pioneering patients. Dr. Borovetz is a professor and chair in the Department of Bioengineering at the University of Pittsburgh, a professor of Chemical and Petroleum Engineering, and the Robert L. Hardesty Professor in the Department of Surgery as well as the Deputy Director of Artificial Organs and Medical Devices. Mr. Winowich is the Senior Biomedical Engineer and Director of Operations at Vital Engineering.

For more information about the Artificial Heart Program, please click here.

For more information about Dr. Borovetz, please click here.

For more information about Mr. Winowich, please click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #84 – Peter DeComo

Regenerative Medicine Today welcomes Mr. Peter DeComo.  Mr. DeComo is the Chairman and Chief Executive Officer of ALung Technologies, Inc., a company which develops respiratory assist technologies that are expected to provide a better alternative to traditional, invasive respiratory support.  Mr. DeComo discusses the goal of ALung to advance lung replacement therapy as well as the challenges it faces as it nears its goals.

For more information about the ALung Technologies, Inc., please click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #70 – Kormos and Haas

Regenerative Medicine Today welcomes back Robert Kormos, MD.  Dr. Kormos is the medical director of the McGowan Institute for Regenerative Medicine’s Clinical Translation Program.  With Dr. Kormos is a former patient, Erika Haas.  They discuss Erika’s experience with Ventricular Assist Device and how VADs were used as a bridge to recovery.

For more information about Robert Kormos, MD, please click here.

For more information about the Clinical Translation Program, please click here.

To listen to Dr. Kormos’s previous podcast, please click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

RMT Podcast #66 – Wearden and Gradowski

Regenerative Medicine Today welcomes back Peter Wearden, MD, PhD.  Dr. Wearden is an Assistant Professor-Pediatric Cardiac Surgery, Director Pediatric Mechanical Cardiopulmonary Support at the Children’s Hospital of Pittsburgh, and a faculty member at the McGowan Institute for Regenerative Medicine.  Joining Dr. Wearden is Dr. Joel Gradowski and Cindy Gradowski, who discuss their son’s recent cardiac treatment and recovery through the use of a Ventricular Assist Device.

For more information on Dr. Wearden, please click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #49 – Stephen Winowich

Steve Winowich is the Director of Clinical Bioengineering with the Artificial Heart Program at the University of Pittsburgh Medical Center (UPMC) and he is also the Chief Operating Officer of Vital Engineering, Inc.

Mr. Winowich describes a unique partnership between the clinical staff and a team of bioengineers and nurses who are a key component of a very successful program that provides mechanical circulatory support to patients that are waiting for a heart transplant.  Supplemental circulatory support has been traditionally used as a bridge to a transplant, but there are also cases where the circulatory support has also been used as a bridge to recovery.

The discussion includes a synopsis of the current state-of-the-art and a review of how artificial heart technology has improved over the years.  The program at UPMC has matured and through Vital Engineering, Inc. bioengineering support for mechanical circulatory support is now provided around the world.

Click here for more information on the Artificial Heart Program

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #44 – Peter Wearden, MD, PhD

Regenerative Medicine Today welcomes Peter Wearden, MD, PhD.  Dr. Wearden is an Assistant Professor-Pediatric Cardiac Surgery, Director Pediatric Mechanical Cardiopulmonary Support at the Children’s Hospital of Pittsburgh, and a faculty member at the McGowan Institute for Regenerative Medicine.

Dr. Wearden discusses his pioneering clinical initiatives in pediatric cardiac care as well as his collaborative research in the development and assessment of pediatric mechanical circulatory support systems. He also shares his vision for the future with new procedures that could dramatically affect the treatments for children with cardiac afflictions.

For more information about Dr. Wearden, click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #26 – Robert Eberhart, PhD

Many of our listeners are familiar with intravascular stents, a commonly used tool to help treat coronary artery disease. The stents used today are metallic, and some of the stents are coated to reduce the post-implant complications of this “foreign” device being inserted in the body.

In today’s podcast, Dr. Robert Eberhart discusses the research that he and his colleagues are pursuing to bring to clinical practice a radically different design of an intravascular stent.  Dr. Eberhart is a Professor, Department of Engineering in Surgery, University of Texas Southwestern.

The device that has been developed in the Eberhart Labs is a bioresorbable poly-(L-lactic Acid) stent that is porous enough so that drugs can be implanted in the stent and slowly released over an extended period of time.

Interestingly, this polymer stent can be implanted with drugs like curcumin, an extract of turmeric.  Some believe that curcumin has many therapeutic effects.  As an example, India consumes 90% of the world’s consumption of the spice curcumin, and in the opinion of some investigators, may be the reason for a reduced incidence of Alzheimer’s in India

For more information about Dr. Eberhart’s work please click here.

Hosts Leah Kauffman and John Murphy. Interview by Leah Kauffman.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #24 – Alan Russell, PhD

As Regenerative Medicine Today celebrates its first anniversary, we welcome back our first guest from December 2005: Dr. Alan Russell, director of the McGowan Institute for Regenerative Medicine.

As a pioneer of and expert in regenerative medicine, Dr. Russell is well qualified to comment on the status and future of this fascinating and rapidly emerging field . In this podcast, Dr. Russell addresses:

  • the history of the emergence of regenerative medicine, from over-hyped laboratory results, to failed medical devices, to successful clinical applications;
  • the role of governments in the advancing the state-of- the-art and the clinical use of regenerative medicine technologies;
  • initiatives to assist soldiers (and, ultimately, the civilian population) who have suffered massive loss of tissue due to trauma, and;
  • the status of the professional society that serves the scientists who are developing regenerative medicine technologies.

Hosts Leah Kauffman and John Murphy. Interview by Leah Kauffman.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

RMT Podcast #23 – Peter DeComo

According to the National Institutes of Health, nearly 300,00 people in the United States with kidney failure visit a clinic three or four days a week for four to six hours of dialysis. Imagine if these patients could have their blood cleansed of impurities while they slept in their own beds. In this podcast, Mr. Peter DeComo, a co-founder of Renal Solutions, Inc., describes an innovative dialysis system that people can use at home.

As we’ll hear from Mr. DeComo, Renal Solutions’ home dialysis system frees patients’ daylight hours and helps preserve their health because it provides gentle, efficient filtering at higher doses than traditional dialysis machines.

The Renal Solutions home dialysis system has FDA approval and will be available in early 2007.

Hosts Leah Kauffman and John Murphy. Interview by Leah Kauffman.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #19 – Robert Kormos, MD

Our last podcast featured the bioengineer responsible for much of today’s artificial heart technology. Now meet Dr. Robert Kormos, a clinician who has used those artificial hearts to help people survive until donor hearts were available. Some patients even recovered enough heart function to eliminate the need for transplantation.

Dr. Kormos is the medical director of the McGowan Institute for Regenerative Medicine and director of the UPMC Artificial Heart Program. As the Artificial Heart Program celebrates its 20th anniversary, patients of the program have been collectively sustained by their artificial hearts for more than 50 years. In this podcast, Dr. Kormos discusses the evolution of his program and the clinical use of artificial hearts, and he tells us how regenerative medicine will continue to transform the treatment of heart failure.

For more information about Dr. Kormos, click here.

For information on artificial heart treatments at UPMC, click here.

For information on heart device research at the McGowan Institute for Regenerative Medicine, click here.

Hosts Leah Kauffman and John Murphy. Interview by Leah Kauffman.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook

By |Tags: |
Load More Posts